Literature DB >> 30865010

The unique role of the trigeminal autonomic reflex and its modulation in primary headache disorders.

Maike Möller1, Arne May.   

Abstract

PURPOSE OF REVIEW: The trigeminal autonomic reflex is a physiological reflex with an important protective function which also plays a role in pathophysiological conditions, such as primary headache. It is not understood whether the autonomic symptoms in trigeminal autonomic cephalalgias and migraine are the consequence of severe trigeminal discharge or indeed directly driven by central generators as part of the pathophysiology, underlying these syndromes. RECENT
FINDINGS: Modulating this reflex, and particularly the parasympathetic reflex arc, has been shown to be effective in treating headache. Among these modulators, left noninvasive vagal nerve stimulation has been shown to bilaterally inhibit the parasympathetic output of the reflex. Furthermore, the peripheral activation of the reflex, resulting in parasympathetic discharge, is not sufficient to provoke headache attacks in cluster headache patients, suggesting a central modulation.
SUMMARY: Here, we review the anatomy and physiology of the trigeminal autonomic reflex and its involvement in primary headache. Possible candidates who have a modulating effect, including neurostimulation and pharmacological approaches, are described.

Entities:  

Mesh:

Year:  2019        PMID: 30865010     DOI: 10.1097/WCO.0000000000000691

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  3 in total

1.  Cluster headache is one of the most intensely painful human conditions: Results from the International Cluster Headache Questionnaire.

Authors:  Mark J Burish; Stuart M Pearson; Robert E Shapiro; Wei Zhang; Larry I Schor
Journal:  Headache       Date:  2020-12-18       Impact factor: 5.887

2.  Indomethacin has no effect on trigeminally provoked parasympathetic output.

Authors:  Maike Möller; Celina Schröder; Stefanie Iwersen-Bergmann; Jan Mehnert; Arne May
Journal:  Cephalalgia       Date:  2021-08-18       Impact factor: 6.292

3.  Cranial autonomic symptoms and response to monoclonal antibodies targeting the Calcitonin gene-related peptide pathway: A real-world study.

Authors:  Eleonora De Matteis; Valeria Caponnetto; Alfonsina Casalena; Ilaria Frattale; Amleto Gabriele; Giannapia Affaitati; Maria Adele Giamberardino; Maurizio Maddestra; Stefano Viola; Francesca Pistoia; Simona Sacco; Raffaele Ornello
Journal:  Front Neurol       Date:  2022-09-23       Impact factor: 4.086

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.